1-(4-tert-Butylbenzoyl)-3-(5-methyl-1,2-oxazol-3-yl)thiourea

Catalog No. :
ACEXXF766
CAS No. :
477508-64-8
Molecular Formula :
C16H19N3O2S
Molecular Weight :
317.41

IUPAC Name:4-(tert-butyl)-N-((5-methylisoxazol-3-yl)carbamothioyl)benzamide

1-(4-tert-Butylbenzoyl)-3-(5-methyl-1,2-oxazol-3-yl)thiourea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$285.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-tert-Butylbenzoyl)-3-(5-methyl-1,2-oxazol-3-yl)thiourea
IUPAC Name4-(tert-butyl)-N-((5-methylisoxazol-3-yl)carbamothioyl)benzamide
MDL No.MFCD01567644
Molecular FormulaC16H19N3O2S
Molecular Weight317.41
SMILESS=C(NC1=NOC(C)=C1)NC(C2=CC=C(C(C)(C)C)C=C2)=O
InChI KeyHIIVZHZZXICMDD-UHFFFAOYSA-N
Synonym1-(4-(TERT-BUTYL)BENZOYL)-3-(5-METHYLISOXAZOL-3-YL)THIOUREA;1-(4-tert-butylbenzoyl)-3-(5-methyl-1,2-oxazol-3-yl)thiourea;Benzamide, 4-(1,1-dimethylethyl)-N-[[(5-methyl-3-isoxazolyl)amino]thioxomethyl]-
CAS No.477508-64-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEXXF766 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOULY350 route compound structure diagram
    ACOULY3501072-67-9 In Stock
  4. Then
  5. ACEXXF766 route product structure diagram
    ACEXXF766477508-64-8
Inquiry

2. ACEXXF766 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIDQF180 route compound structure diagram
    ACIDQF18056108-12-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEXXF766 route product structure diagram
    ACEXXF766477508-64-8
Inquiry

Comments (0)